Recruiting NA Psoriasis

New treatment option for Psoriasis

Official title Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients

ClinicalTrials.gov ID: NCT06893913

What this study is testing

What it's testing
insulin resistant psoriatic obese patients may complain problems of dryness of eye. Intermittent fasting may improve dryness of eye, obesity, insulin resistance, and psoriasis.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 45 to 55

You may be able to join if

  • chronic plaque psoriasis
  • obesity class I
  • prediabetic persons
  • dryness of both eyes

You likely can't join if

  • cardiac insults
  • respiratory insults
  • diabetics hypertensives or renal, hepatic insults

The study team makes the final eligibility decision.

Where it's taking place

  • Giza, Dokki, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 45 years to 55 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Giza, Dokki, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.